General control nonderepressible 2 (GCN2) as a therapeutic target in age-related diseases

被引：0
|
作者：
Altintas, Ozlem [1 ]
MacArthur, Michael R. [1 ,2 ]
机构：
[1] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland
[2] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA
来源：
FRONTIERS IN AGING | 2024年 / 5卷
关键词：
GCN2; ISR; amino acids; aging; gerotherapeutic; geroprotection; cancer; AMINO-ACID DEPRIVATION; PROTEIN-KINASE GCN2; SENSOR GCN2; TRANSLATIONAL CONTROL; TRANSFER-RNA; T-CELLS; ACTIVATION; STRESS; BINDING; PHOSPHORYLATION;
D O I：
10.3389/fragi.2024.1447370
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
The function of General Control Nonderepressible 2 (GCN2), an evolutionary-conserved component of the integrated stress response (ISR), has been well-documented across organisms from yeast to mammals. Recently GCN2 has also gained attention for its role in health and disease states. In this review, we provide a brief overview of GCN2, including its structure, activation mechanisms and interacting partners, and explore its potential significance as a therapeutic target in various age-related diseases including neurodegeneration, inflammatory disorders and cancer. Finally, we summarize the barriers to effectively targeting GCN2 for the treatment of disease and to promote a healthier aging process.
引用
收藏
页数：8
相关论文
共 50 条
  • [21] Sigma-2 Receptors-From Basic Biology to Therapeutic Target: A Focus on Age-Related Degenerative Diseases
    Lizama, Britney N.
    Kahle, Jennifer
    Catalano, Susan M.
    Caggiano, Anthony O.
    Grundman, Michael
    Hamby, Mary E.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [22] GCN2 controls the cellular checkpoint: potential target for regulating inflammation
    Xiaojing Xia
    Liancheng Lei
    Wanhai Qin
    Lei Wang
    Gaiping Zhang
    Jianhe Hu
    Cell Death Discovery, 4
  • [23] Oxidative Stress in Age-Related Macular Degeneration: Nrf2 as Therapeutic Target
    Bellezza, Ilaria
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [24] ERK1/2 activation is a therapeutic target in age-related macular degeneration
    Dridi, Sami
    Hirano, Yoshio
    Tarallo, Valeria
    Kim, Younghee
    Fowler, Benjamin J.
    Ambati, Balamurali K.
    Bogdanovich, Sasha
    Chiodo, Vince A.
    Hauswirth, William W.
    Kugel, Jennifer F.
    Goodrich, James A.
    Ponicsan, Steven L.
    Hinton, David R.
    Kleinman, Mark E.
    Baffi, Judit Z.
    Gelfand, Bradley D.
    Ambati, Jayakrishna
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (34) : 13781 - 13786
  • [25] The Elastin Receptor Complex: An Emerging Therapeutic Target Against Age-Related Vascular Diseases
    Tembely, Digne
    Henry, Auberi
    Vanalderwiert, Laetitia
    Toussaint, Kevin
    Bennasroune, Amar
    Blaise, Sebastien
    Sartelet, Herve
    Jaisson, Stephane
    Gales, Celine
    Martiny, Laurent
    Duca, Laurent
    Romier-Crouzet, Beatrice
    Maurice, Pascal
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [26] Modulators of ASIC1a and its potential as a therapeutic target for age-related diseases
    Zhou, Ren-Peng
    Liang, Hong-Yu
    Hu, Wei-Rong
    Ding, Jie
    Li, Shu-Fang
    Chen, Yong
    Zhao, Ying-Jie
    Lu, Chao
    Chen, Fei-Hu
    Hu, Wei
    AGEING RESEARCH REVIEWS, 2023, 83
  • [27] Potential therapeutic target for aging and age-related neurodegenerative diseases: the role of acid sphingomyelinase
    Min Hee Park
    Hee Kyung Jin
    Jae-sung Bae
    Experimental & Molecular Medicine, 2020, 52 : 380 - 389
  • [28] Potential therapeutic target for aging and age-related neurodegenerative diseases: the role of acid sphingomyelinase
    Park, Min Hee
    Jin, Hee Kyung
    Bae, Jae-sung
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2020, 52 (03): : 380 - 389
  • [29] General control non-derepressible 2 (GCN2) in T cells controls disease progression of autoimmune neuroinflammation
    Keil, Melanie
    Sonner, Jana K.
    Lanz, Tobias V.
    Oezen, Iris
    Bunse, Theresa
    Bittner, Stefan
    Meyer, Hannah V.
    Meuth, Sven G.
    Wick, Wolfgang
    Platten, Michael
    JOURNAL OF NEUROIMMUNOLOGY, 2016, 297 : 117 - 126
  • [30] GCN2 regulates BMP signaling: consequence for PVOD pathobiology and therapeutic management
    Manaud, Gregoire
    Lambert, Melanie
    Soilih, Bahgat
    Girerd, Barbara
    Soubrier, Florent
    Bignard, Juliette
    Claude, Olivier
    Lecerf, Florence
    Florio, Monica
    Sun, Banghua
    Nadaud, Sophie
    Verleden, Stjin
    Remy, Severine
    Anegon, Ignacio
    Mercier, Olaf
    Fadel, Elie
    Simmoneau, Gerald
    Humbert, Marc
    Montani, David
    Antigny, Fabrice
    Perros, Frederic
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
12345